Wells Fargo’s Avenue Therapeutics, Inc. Common Stock ATXI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-500
| Closed | -$1K | – | 6682 |
|
2024
Q4 | $1K | Sell |
500
-61
| -11% | -$122 | ﹤0.01% | 5754 |
|
2024
Q3 | $1.4K | Buy |
561
+500
| +820% | +$1.25K | ﹤0.01% | 5681 |
|
2024
Q2 | $214 | Sell |
61
-3
| -5% | -$11 | ﹤0.01% | 5813 |
|
2024
Q1 | $709 | Buy |
64
+2
| +3% | +$22 | ﹤0.01% | 5834 |
|
2023
Q4 | $745 | Buy |
62
+1
| +2% | +$12 | ﹤0.01% | 5855 |
|
2023
Q3 | $3.24K | Hold |
61
| – | – | ﹤0.01% | 5647 |
|
2023
Q2 | $5.37K | Hold |
61
| – | – | ﹤0.01% | 5762 |
|
2023
Q1 | $5.32K | Hold |
61
| – | – | ﹤0.01% | 5715 |
|
2022
Q4 | $5.29K | Hold |
61
| – | – | ﹤0.01% | 5431 |
|
2022
Q3 | $46K | Hold |
61
| – | – | ﹤0.01% | 4698 |
|
2022
Q2 | $18K | Buy |
61
+18
| +42% | +$5.31K | ﹤0.01% | 5225 |
|
2022
Q1 | $23K | Hold |
43
| – | – | ﹤0.01% | 5630 |
|
2021
Q4 | $44K | Hold |
43
| – | – | ﹤0.01% | 5569 |
|
2021
Q3 | $72K | Buy |
+43
| New | +$72K | ﹤0.01% | 5202 |
|
2021
Q2 | – | Sell |
-3
| Closed | -$22K | – | 7148 |
|
2021
Q1 | $22K | Sell |
3
-12
| -80% | -$88K | ﹤0.01% | 5762 |
|
2020
Q4 | $98K | Sell |
15
-2
| -12% | -$13.1K | ﹤0.01% | 5204 |
|
2020
Q3 | $205K | Buy |
17
+6
| +55% | +$72.4K | ﹤0.01% | 4785 |
|
2020
Q2 | $128K | Buy |
+11
| New | +$128K | ﹤0.01% | 4915 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 6487 |
|
2019
Q3 | – | Hold |
0
| – | – | – | 6252 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 6244 |
|